LP101309-5
Zanamivir
Active
Description
Zanamivir (INN) is a neuraminidase inhibitor used in the treatment and prophylaxis of Influenzavirus A and Influenzavirus B. Zanamivir was the first neuraminidase inhibitor commercially developed. It is currently marketed by GlaxoSmithKline under the trade name Relenza. According to the Centers for Disease Control and Prevention (CDC), no flu, seasonal or pandemic, has shown any signs of resistance to zanamivir. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, wikipedia
Basic Part Properties
- Part Display Name
- Zanamivir
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2010-07-22
- Construct for LOINC Short Name
- Zanamivir
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP101309-5 - ConceptMap translate
- https:
//fhir.loinc.org/ConceptMap/$translate?system=http: //loinc.org&code=LP101309-5
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| zh-CN | Chinese (China) | 扎那米韦 Synonyms: 瑞乐沙 |
| fr-CA | French (Canada) | Zanamivir |
| es-ES | Spanish (Spain) | Zanamivir |
| it-IT | Italian (Italy) | Zanamivir |
| tr-TR | Turkish (Turkey) | Zanamivir |
| ru-RU | Russian (Russian Federation) | Занамивир |
| nl-NL | Dutch (Netherlands) | Zanamivir |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright